14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.71 $3.40 Tuesday, 23rd Apr 2024 ESPR stock ended at $2.09. This is 9.42% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 10.12% from a day low at $1.93 to a day high of $2.13.
90 days $1.71 $3.40
52 weeks $0.700 $3.40

Historical Esperion Therapeutics prices

Date Open High Low Close Volume
Aug 11, 2023 $1.66 $1.74 $1.64 $1.73 1 078 024
Aug 10, 2023 $1.59 $1.73 $1.59 $1.68 3 886 909
Aug 09, 2023 $1.63 $1.68 $1.51 $1.59 3 991 456
Aug 08, 2023 $1.60 $1.75 $1.58 $1.62 4 550 713
Aug 07, 2023 $1.70 $1.70 $1.54 $1.59 2 415 904
Aug 04, 2023 $1.65 $1.72 $1.62 $1.63 2 807 168
Aug 03, 2023 $1.77 $1.79 $1.63 $1.64 3 962 860
Aug 02, 2023 $1.63 $1.99 $1.63 $1.79 7 117 172
Aug 01, 2023 $1.69 $1.87 $1.56 $1.69 8 911 213
Jul 31, 2023 $1.55 $1.64 $1.52 $1.57 2 551 213
Jul 28, 2023 $1.42 $1.55 $1.40 $1.53 1 780 995
Jul 27, 2023 $1.42 $1.46 $1.36 $1.39 1 336 898
Jul 26, 2023 $1.42 $1.46 $1.40 $1.42 1 099 045
Jul 25, 2023 $1.48 $1.50 $1.41 $1.44 1 500 443
Jul 24, 2023 $1.56 $1.57 $1.44 $1.47 2 390 059
Jul 21, 2023 $1.50 $1.58 $1.46 $1.53 2 034 560
Jul 20, 2023 $1.56 $1.61 $1.50 $1.50 1 752 623
Jul 19, 2023 $1.57 $1.61 $1.54 $1.54 2 007 884
Jul 18, 2023 $1.52 $1.66 $1.50 $1.57 3 417 471
Jul 17, 2023 $1.44 $1.52 $1.42 $1.49 1 353 629
Jul 14, 2023 $1.52 $1.52 $1.43 $1.44 1 351 876
Jul 13, 2023 $1.62 $1.67 $1.49 $1.51 2 909 995
Jul 12, 2023 $1.62 $1.68 $1.58 $1.66 1 618 793
Jul 11, 2023 $1.63 $1.65 $1.58 $1.61 1 674 337
Jul 10, 2023 $1.54 $1.62 $1.48 $1.61 1 725 046
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT